Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yamaguchi, Masaki  [Clear All Filters]
2023
Kamijo K, Shimomura Y, Shinohara A, Mizuno S, Kanaya M, Usui Y, Kim S-W, Ara T, Mizuno I, Kuriyama T, et al. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation. Ann Hematol. 2023.
Sawazaki A, Sugimori C, Yamaguchi M, Nakao S. Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma. Transfus Apher Sci. 2023:103649.
2022
Röth A, Broome CM, Barcellini W, Jilma B, Hill QA, Cella D, Tvedt THenrik And, Yamaguchi M, Lee M, Shafer F, et al. Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study. Eur J Haematol. 2022.
2020
Harada Y, Shingai N, Ding Y, Sadato D, Hayashi Y, Yamaguchi M, Okuyama Y, Shimoyama T, Ohashi K, Harada H. Gene Rearrangements of MLL and RUNX1 Sporadically Occur in Normal CD34 Cells Under Cytokine Stimulation. Cancer Sci. 2020.
2019
Sato K, Ishiyama K, Aoki G, Maruyama H, Tsuji N, Tanabe M, Zaimoku Y, Sato H, Yamazaki H, Yamaguchi M, et al. Evaluation of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in Japanese healthy donors: a prospective study. Int J Hematol. 2019.